logo
Plus   Neg
Share
Email

Intuit Sees Lower Q3 Revenue; Stock Down

Shares of Intuit Inc. (INTU) sank 6 percent on Friday after the financial software provider said it expects third-quarter revenue to be at or slightly below the low end of its prior guidance, citing softness in the digital tax prep category. The company estimates earnings for the period to be within its previous outlook.

Intuit in February had forecast third-quarter revenue of $1.95 billion to $1.99 billion, net earnings of $2.36 to $2.40 per share, and adjusted earnings of $2.47 to $2.51 per share.

Analysts polled by Thomson Reuters currently expect revenue of $1.97 billion and earnings of $2.49 per share for the quarter. Analysts' estimates typically exclude special items.

For the full year 2012, Intuit said it continues to expect net earnings of $2.43 to $2.50 per share, and adjusted earnings of $2.90 to $2.97 per share. Analysts currently expect earnings of $2.96 per share.

Intuit expects full year 2012 consumer tax revenue to grow 11 percent.

Intuit provides financial management solutions for small and medium-sized firms, accounting professionals, and others. Its flagship products include QuickBooks, TurboTax and Quicken.

Detailing its performance through April 18, 2012, Intuit said its offerings of TurboTax federal units rose 6 percent from last year, and TurboTax Online units were up 11 percent.

"Our revenue growth this year benefited from positive mix shifts within our TurboTax product lineup," said Dan Maurer, senior vice president and general manager of Intuit's consumer group.

"While the digital tax prep category grew at the lower end of our expectations this year, we believe we gained about one point of share online and are well positioned for long-term growth."

INTU is trading at $57.38, down $3.52 or 5.78%, on a volume of about 11 million shares on the Nasdaq.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

More Breaking News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT